Medicine
Kineret 100 mg/0.67 mL injection
Kineret 100 mg/0.67 mL injection is a prescription medicine containing Anakinra for subcutaneous use, marketed by Swedish Orphan Biovitrum AB (publ), with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
KINERET should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F). DO…
Key facts
- Active ingredient (INN)
- Anakinra
- Brand
- Kineret
- Strength
- 100 mg/0.67 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 7 syringes of 0.67 mL, 4 cartons of 0.67 mL
- Marketing authorisation holder
- Swedish Orphan Biovitrum AB (publ)
- Manufacturer
- Swedish Orphan Biovitrum AB (publ)
- Origin register
- US FDA, United States
- Storage
- KINERET should be stored in the refrigerator at 2°C to 8°C (36°F to 46°F). DO NOT FREEZE OR SHAKE. Protect from light.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L04AC03 Anakinra
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 15 December 2009
- Identifiers
- RxCUI 727711, 727714DailyMed set ID d9d74915-6606-4570-9c52-c4001d3177deNDC 66658-234Application BLA103950
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 7 syringe, glass in 1 carton / .67 mL in 1 syringe, glass | 66658-234-07 | Swedish Orphan Biovitrum AB (publ) | 15 December 2009 |
| 4 carton in 1 case / 7 syringe, glass in 1 carton / .67 mL in 1 syringe, glass | 66658-234-28 | Swedish Orphan Biovitrum AB (publ) | 15 December 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Anakinra is an interleukin-1 receptor antagonist indicated for rheumatoid Arthritis (RA) Reduction in signs and symptoms and slowing the progression of structural damage in moderately to severely active rheumatoid arthritis, among other approved uses. MedsAcross supplies Anakinra for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AnakinraFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Kineret prescribing information (Swedish Orphan Biovitrum AB (publ)) · U.S. National Library of Medicine, DailyMed
- Kineret: European public assessment report (EPAR) · European Medicines Agency
Need Kineret 100 mg/0.67 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.